Zydus Lifesciences informed the NSE that its indirect wholly owned subsidiary, Amplitude SAS, acquired 100% share capital of France-based FBC Medical for a cash consideration of Euro 700,000.

FBC Medical, incorporated in 2016, operates in the medical equipment distribution segment and functions as an exclusive sales agent for Amplitude Surgical across multiple French regions. The acquisition aims to strengthen Zydus Lifesciences’ commercial presence in Europe by bringing distribution capabilities in-house and reducing long-term selling and distribution costs. 

According to the company’s disclosure, the transaction was completed on April 30, 2026. FBC Medical reported a turnover of Euro 935,000 in FY2025, compared to Euro 951,000 in FY2024 and Euro 924,000 in FY2023.